Cumberland Pharmaceuticals Reports First Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Cumberland Pharma (CPIX) Reports Q1 EPS of $0.02
May 10, 2016 4:28 PM EDTCumberland Pharma (NASDAQ: CPIX) reported Q1 EPS of $0.02, versus $0.09 reported last year. Revenue for the quarter came in at $7.7 million, versus $8.7 million reported last year.
For earnings history and earnings-related data on Cumberland Pharma (CPIX) click here.
... More